This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Fresenius Medical Care AG & Co. KGaA (FMS)

NYSE: Health Care

Company Income Statement
Dec 2015 Dec 2014 Dec 2013 Dec 2012
Sales 16.74B 15.83B 14.61B 13.80B
Cost of Sales 10.69B 10.14B 9.22B 8.60B
Gross Operating Profit 6.05B 5.70B 5.39B 5.20B
Selling, General, and Administrative Expenses 2.90B 2.64B 2.39B 2.32B
Research & Development 140.30M 122.11M 125.81M 111.63M
Operating Income before D & A (EBITDA) 3.01B 2.93B 2.87B 2.77B
Depreciation & Amortization 717.32M 699.33M 648.23M 602.90M
Interest Income 116.58M 84.24M 38.94M 44.47M
Other Income - Net 31.45M 25.46M 9.43M 193.27M
Special Income / Charges 0.00 0.00 26.11M 0.00
Total Income Before Interest Expenses (EBIT) 2.44B 2.34B 2.30B 2.40B
Interest Expense 508.04M 495.37M 447.50M 470.53M
Pre-Tax Income 1.94B 1.84B 1.85B 1.93B
Income Taxes 622.12M 583.60M 592.01M 605.14M
Minority Interest 283.70M 214.54M 145.73M 140.17M
Net Income From Continuing Operations 1.31B 1.26B 1.26B 1.33B
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations 1.31B 1.26B 1.26B 1.33B
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 1.03B 1.05B 1.11B 1.19B
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
1.31B 1.26B 1.23B 1.33B
Preferred Dividends
Net Income Available To Common 1.31B 1.26B 1.26B 1.33B
Basic EPS from Continuing Ops. 1.69 1.73 1.83 1.94
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations 1.69 1.73 1.83 1.94
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total 1.69 1.73 1.83 1.95
Basic Normalized Net Income/Share 1.69 1.73 1.79 1.94
EPS fr Continuing Ops. 1.69 1.73 1.82 1.93
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. 1.69 1.73 1.82 1.93
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total 1.69 1.73 1.83 1.94
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
1.69 1.73 1.78 1.93
Dividends Paid per Share 0.43 0.53 0.33 0.44
FMS News

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

FMS Fresenius Medical Care AG & Co. KGaA

Chart of FMS

Analysts Ratings for FMS

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 1 1 1 1
Moderate Buy 0 0 0 0
Hold 5 5 6 7
Moderate Sell 1 0 0 1
Strong Sell 0 0 0 0
GET FMS ANALYST REPORT

FMS Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs